Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
NEW REPORT: DRUGMAKERS’ 340B REBATE SCHEMES THREATEN MASSIVE FINANCIAL HARM TO SAFETY-NET HOSPITALS
-
340B HEALTH RESPONDS TO CMS PROPOSALS TO ACCELERATE PAY REDUCTIONS TO 340B HOSPITALS AND PURSUE NEW CUTS
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
340B HEALTH RESPONDS TO FEDERAL COURT DECISION ON DRUGMAKERS’ REBATE SCHEMES
-
340B HEALTH RESPONDS TO SEN. CASSIDY’S REPORT ON THE 340B DRUG PRICING PROGRAM
-
340B HEALTH SUBMITS MOTIONS TO INTERVENE IN ALL DRUGMAKER REBATE LAWSUITS
-
340B HEALTH FILES MOTION TO INTERVENE IN J&J REBATE LAWSUIT
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
340B HEALTH STATEMENT ON 340B DRUG PURCHASE DATA FOR 2023
-
340B HEALTH APPLAUDS HRSA’S ACTION TO PROTECT 340B FROM J&J’S REBATE SCHEME
-
SENATE COMPANION BILL WOULD END DRUG COMPANY RESTRICTIONS ON 340B
-
340B HEALTH URGES HRSA TO BLOCK J&J PLAN TO REPLACE 340B DISCOUNTS WITH REBATES